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1. Introduction  
Biomaterials are considered those natural or artificial materials that can be used for any 
period of time, as a whole or as part of a system which treats, augments or replaces a tissue, 
organ or function of the human or animal body (Williams, 1999). In medicine a wide range 
of biomaterials based on metals, ceramics, synthetic polymers, biopolymers, etc. is used. 
Among biopolymers, collagen represents one of the most used biomaterials due to its 
excellent biocompatibility, biodegradability and weak antigenecity, well-established 
structure, biologic characteristics and to the way it interacts with the body, the latter 
recognizing it as one of its constituents and not as an unknown material (Friess, 1998; Lee et 
al., 2001). Irrespective of the progress in the field of biomaterials based on synthetic 
polymers, collagen remains one of the most important natural biomaterials for connective 
tissue prosthetic in which it is the main protein. Due to its excellent properties collagen can 
be processed in different biomaterials used as burn/wound dressings, osteogenic and bone 
filling materials, antithrombogenic surfaces, collagen shields in ophthalmology, being also 
used for tissue engineering including skin replacement, bone substitutes, and artificial blood 
vessels and valves. Biomaterials based on type I fibrillar collagen such as medical devices, 
artificial implants, drug carriers for controlled release and scaffolds for tissue regeneration 
have an important role in medicine, being widely used at present (Healy et al., 1999; Hubell, 
1999; Wang et al., 2004). In this chapter, we attempted to summarize some of the recent 
developments in the application of collagen as biomaterial in drug delivery systems and 
tissue engineering field. 
2. Collagen-based biomaterials 
Collagen is the main fibrous protein constituent in skin, tendons, ligaments, cornea etc. It 
has been extensively isolated from various animals, including bovine (Renou et al., 2004; 
Doillon, 1992), porcine (Smith et al., 2000; Lin et al., 2011; Parker et al., 2006), equine (Angele 
et al., 2004), ovine (Edwards et al., 1992), shark, frog, bird (Limpisophon et al., 2009) and 
from marine origin such as: catfish (Singh et al., 2011), silver carp (Rodziewicz-Motowidło et 
al., 2008), marine sponge (Swatschek et al., 2002), jumbo squid (Uriarte-Montoya et al., 2010), 
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paper nautilus (Nagai & Suzuki, 2002), tilapia fish-scale (Chen et al., 2011), red fish (Wang et 
al., 2008). Among these types of sources the most used has been bovine hide. Although to 
date 29 different types of collagen have been identified (Albu, 2011), type I collagen is the 
most abundant and still the best studied. This work is focused on biomaterials based on type 
I collagen of bovine origin. Type I collagen consists of 20 amino acids, arranged in 
characteristic sequences which form a unique conformational structure of triple helix 
(Trandafir et al., 2007). Hydroxyproline is characteristic only for collagen and it confers 
stability for collagen, especially by intramolecular hydrogen bonds. The collagen structure is 
very complex, being organised in four levels, named primary, secondary, tertiary and 
quaternary structure. Depending on the process of collagen extraction, the basic forms of 
collagen are organized on structural level. 
2.1 Process of collagen extraction  
To obtain extracts of type I fibrillar collagen, fresh skin or skin technological waste from 
leather industry can be used as raw materials (Trandafir et al., 2007), extraction being 
performed from dermis. To minimize the exogenous degradation the skin has to be ready 
for immediate extraction. Yield of good extraction is obtained from skin of young animals 
(preferably younger than two years) due to weaker crosslinked collagen. 
Figure 1 schematically shows the obtaining of collagen in different forms by the currently 
used technologies at Collagen Department of Leather and Footwear Research Institute, 
Bucharest, Romania. 
As figure 1 shows, the bovine hide was used as raw material. After removal of hair and fat 
by chemical, enzymatic or mechanical process, the obtained dermis could undergo different 
treatment and soluble or insoluble collagen is obtained.  
2.1.1 Process of extraction for soluble collagen 
Depending on structural level the solubilised collagen extracts can be denatured (when 90% 
of molecules are in denatured state) or un-denatured (when 70% of molecules keep their 
triple helical structure) (Trandafir et al., 2007).  
The process for obtaining of denatured collagen took place at high temperature, pressure or 
concentrated chemical (acid or alkali) or enzymatic agents. Following these critical 
conditions the collagen is solubilised until secondary or primary level of structure and 
gelatine or partial (polypeptide) and total (amino acids) hydrolisates are obtained. 
The undenatured collagen can be isolated and purified by two technologies, depending on the 
desired structural level (Li, 2003): molecular and fibrillar. They allow the extraction of type I 
collagen from bovine hide in aqueous medium while maintaining the triple helical structure 
of molecules, of microfibrils and fibres respectively (Wallace & Rosenblatt, 2003). 
Isolation and purification of collagen molecules from collagenic tissues can be performed 
using a proteolytic enzyme such as pepsin, which produces cleavage of telopeptides - places 
responsible for collagen crosslinking. Removing them makes the collagen molecules and 
small aggregates (protofibrils) soluble in aqueous solutions of weak acid or neutral salts.  
Extraction of collagen soluble in neutral salts. Studies on the extraction of soluble collagen with 
neutral salt solutions were performed with 0.15 to 0.20 M sodium chloride at 50C for 1-2 
days (Fielding, 1976). Yield of this technology is low and the most collagenic tissues 
extracted with salts contain small quantities of collagen or no collagen at all.  
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Fig. 1. Basic forms of collagen 
Extraction of acid soluble collagen. Dilute acids as acetic, hydrochloric or citrate buffer solution 
with pH 2-3 are more effective for extraction of molecular collagen than neutral salt 
solutions. Type aldiminic intermolecular bonds are disassociated from dilute acids and by 
exerting forces of repulsion that occur between the same charges on the triple helix, causing 
swelling of fibril structure (Trelstad, 1982). The diluted acids do not dissociate keto-imine 
intermolecular bonds. For this reason collagen from tissues with high percentage of such 
bonds, such as bone, cartilage or tissue of aged animals is extracted in smaller quantities in 
dilute acids. 
To obtain soluble collagen with diluted acids tissue is ground cold, wash with neutral salt to 
remove soluble proteins and polysaccharides, then collagen is extracted with acid solutions 
(Bazin & Delaumay, 1976). Thus about 2% of collagen can be extracted with salts or diluted 
acid solutions. 
Enzymatic extraction is more advantageous, collagen triple helix being relatively resistant to 
proteases such as pronase, ficin, pepsin or chemotripsin at about 20oC (Piez, 1984). The 
efficacy of enzymatic treatment arises from selective cleavage in the terminal non-helical 
regions monomer and higher molecular weight covalently linked aggregates, depending on 
the source and method of preparation. Thus, telopeptidic ends are removed, but in 
appropriate conditions the triple helices remain intact. Solubilised collagen is purified by 
salt precipitation, adjusting pH at the isoelectric value or at temperature of 370C (Bazin & 
Delaumay, 1976). Collagen extracted with pepsin generally contains higher proportions of 
intact molecules extracted with salts or acids.  
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2.1.2 Process of extraction for insoluble collagen 
Collagen extraction by alkaline and enzymatic treatments. Alkaline pretreatment destroys 
covalent bonds resistant to acids. Collagen interaction with alkali shows the presence of 
certain specificities, hydrogen bonds being more sensitive to alkali. Degradation of the 
structure is more intense and irreversible if treatment is progressing on helicoidal structure 
(collagen → gelatin transition, alkaline hydrolysis). 
Breaking of hydrogen bonds occurs by replacing the hydrogen atom from carboxyl groups 
with metal which is unable to form hydrogen bonds. Collagen can be extracted by treating 
the dermis with 5-10% sodium hydroxide and 1 M sodium sulphate at 20-25oC for 48 hours 
(Cioca, 1981; Trandafir et al., 2007). Thus, fats associated with insoluble collagen are 
saponified, the telopeptidic non-helical regions are removed, collagen fibers and fibrils are 
peptized. Size of resulted fragments of collagen depends on the time and concentration of 
alkali treatment (Roreger, 1995). The presence of sodium sulfate solution controlled the 
swelling of collagen structure, protecting the triple-helical native conformation. Alkaline 
treatment is followed by an acid one, which leads to total solubilization of collagen in 
undenatured state from the dermis of mature animals. 
Thus technologies of molecular and fibrilar extraction are enabled to extract type I collagen 
from bovine hide in an aqueous medium keeping triple helical structure of molecules, 
microfibrils and fibrils (Wallace & Rosenblatt, 2003).  
2.2 Obtaining of collagen-based biomaterials 
Obtaining of collagen-based biomaterials starts from undenatured collagen extracts – gels 
and solutions – which are processed by cross-linking, free drying, lyophilization, 
elecrospinning, mineralisation or their combinations. To maintain the triple helix 
conformation of molecules the conditioning processes must use temperatures not higher 
than 300C (Albu et al., 2010a). Extracted as aqueous solution or gel, type I collagen can be 
processed in different forms such as hydrogels, membranes, matrices (spongious), fibers, 
tubes (Fig. 2) that have an important role in medicine today. Figure 2 shows some collagen-
based biomaterials obtained at our Collagen Department. 
Among the variety of collagen-based biomaterials, only the basic morphostructural ones 
will be presented: hydrogels, membranes, matrices, and composites obtained from 
undenatured collagen. 
Collagen hydrogels are biomaterials in the form of tridimensional networks of hydrofil 
polymeric chains obtained by physical or chemical cross-linking of gels. Chemical cross-
linking consists in collagen reaction with aldehydes, diisocyanates, carboimides, acyl-azide, 
polyepoxydes and polyphenolic compounds which lead to the formation of ionic or covalent 
bonds between molecules and fibrils (Albu, 2011). Physical cross-linking includes the drying 
by heating or exposure at UV, gamma or beta irradiations. Their mechanical and biological 
properties are controllable and superior to the gels from which they were obtained. 
The hydrogels have the capacity of hydration through soaking or swelling with water or 
biological fluids; hydrogels with a solid laminar colloidal or solid sphero-colloidal colloidal 
frame are formed, linked by means of secondary valences, where water is included by 
swelling. One of the exclusive properties of hydrogels is their ability to maintain the shape 
during and after soaking, due to the isotropic soaking. Also the mechanical properties of the 
collagen hydrogels are very important for the pharmaceutical applications, the modification 
of the cross-linking degree leading to the desired mechanical properties. The spreading 
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ability of the different size molecules in and from hydrogels serves for their utilization as 
drug release systems. The development and utilization of collagen hydrogels in therapeutics 
is supported by some advantages contributing to patients compliance and product 
efficiency. Thus, the hydrogels are easy to apply, have high bioadhesion, acceptable 
viscosity, compatibility with numerous drugs (Albu & Leca, 2005; Satish et al., 2006; Raub et 
al., 2007). 
 
 
Fig. 2. Collagen-based biomaterials 
 
Collagen membranes/films are obtained by free drying of collagen solution/gel in special 
oven with controllable humidity and temperature (not higher than 25°C) during 48-72 
hours. These conditions allow the collagen molecules from gels to be structured and to form 
intermolecular bonds without any cross-linking agent. They have dense and microporous 
structure (Li et al., 1991). 
Collagen matrices are obtained by lyophilisation (freeze-drying) of collagen solution/gel. 
The specificity of porous structure is the very low specific density, of approximately 0.02-0.3 
g/cm3 (Albu 2011, Zilberman & Elsner, 2008; Stojadinovic et al., 2008; Trandafir et al., 2007). 
The matrix porous structure depends significantly on collagen concentration, freezing rate, 
size of gel fibrils and the presence or absence of cross-linking agent (Albu et al., 2010b). The 
collagen matrix morphological structure is important, influencing the hydrophilicity, drug 
diffusion through network, degradation properties and interaction with cells. Figure 3 
shows characteristic pore structure with a large variation in average pore diameter in 
collagen matrices.  
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a)  b)  c)  
Fig. 3. SEM images of collagen matrices: (a) freeze at -40°C, (b) freeze at -10°C and (c) cross-
linked with 0.25% glutaraldehyde. 
Although the matrices presented in Fig. 3a,b have the same composition, their structure is 
different. Therefore, the low temperature (e.g. -400C) induces about 10 times smaller pore 
sizes than higher temperature (e.g. -100C). It can be noticed that lower freezing temperature 
produces more homogeneous samples than those obtained at high freezing temperature. 
Major differences of pore size and shape appear between un-cross-linked and cross-linked 
samples, the most homogeneous matrix with the smallest and inner pores being the un-
cross-linked obtained at lowest freezing temperature.  
Hydrophilic properties expressed by absorbing water and its vapor, are characteristic for 
collagen matrices, which can absorb at least 1500% water. Permeability for ions and 
macromolecules is of particular importance for tissues which are not based only on the 
vascular transport of nutrients. Diffusion of nutrients into the interstitial space ensures 
survival of the cells, continued ability to grow and to synthesize extracellular matrix 
specifically for tissue. 
The infrared spectra of collagen exhibit several features characteristic for the molecular 
organization of its molecules: amino acids linked together by peptide bonds give rise to 
infrared active vibration modes amide A and B (about 3330 and 3080 cm-1, respectively) and 
amide I, II, and III (about 1629-1658 cm-1, 1550-1560 cm-1 and 1235-1240 cm-1, respectively) 
(Sionkowska et al., 2004). 
Hydrothermal stability of collagen is characterized by its contraction when heated in water 
at a certain temperature at which the conformational transition of molecules from the triple 
helix statistic coil take place (Li, 2003). 
Thermal behavior of collagen matrices depends on the number of intermolecular bonds. 
Generally, the number of bonds is higher, the shrinkage temperature is higher and the 
biomaterial is more stable in vivo. 
Another method commonly used to assess the in vivo stability of collagen biomaterials, is 
the in vitro digestion of matrix with collagenase and other proteinases (trypsin, pepsin) (Li, 
2003). Biodegradability of collagen matrices is dependent on the degree of cross-linking. 
Collagen can form a variety of homogeneous collagen composites with ceramics, drugs, 
natural or synthetic polymers. The obtaining methods involve chemical cross-linking, 
physical loading and co-precipitation followed by free-drying, freeze-drying or 
electrospinning. 
The most recent collagen composites used as medical devices, artificial implants, supports 
for drug release and scaffolds for tissue regeneration are presented in Table 1. 
Collagen composites containing physiologically active substances acting as drug delivery 
systems (DDS) are discussed in Section 3.  
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Type of 
composite 
Type of component from composite Composite form 
Collagen-
natural 
polymer 
Hyaluronic acid (Davidenko et al., 2010) Matrix, membrane, 
hydrogel, fibers 
Silk fibroin (Zhou et al., 2010) Membrane, fibers, 
matrix, microtubes 
Chondroitin-6-suphate (Stadlinger et al., 2008) Tube, matrix 
Elastin (Skopinska-Wisniewska et al., 2009) Tube, film, fibers, matrix  
Alginate (Sang et al., 2011) Spongious, filler for 
bone,  
Chitosan (Sionkowska et al., 2004) Matrix, membrane, 
tubular graft, nanofibers, 
hydrogel,  
Heparin (Stamov et al., 2008) Matrix  
Collagen-
synthetic 
polymer 
Poly-L-lactide (PLLA) (Chen et al.,  2006) Coating for composite 
Poly-lactic-co-glycolic-acid (PLGA) (Wen et al., 
2007) 
Fibers, matrix, coated 
tube 
ε-caprolactone (Schnell et al., 2007) Nanofibers 
Poly(ethylene-glycol) (PEG) (Sionkowska et al., 
2009) 
Films, fibers 
Collagen-
ceramic 
Calcium phosphates (Hong et al., 2011) Matrix, filler 
Hydroxyapatite (Zhang et al., 2010; Hoppe et al., 
2011)  
Matrix, filler 
Tricalciumphosphate (Gotterbarm et al., 2006) Matrix, filler 
Table 1. Collagen-based composites 
3. Collagen-based drug delivery systems 
Nowdays, the field of drug delivery from topical biopolymeric supports has an increased 
development due to its advantages compared to the systemic administration. These 
biopolymers can release adequate quantities of drugs, their degradation properties being 
adjustable for a specific application that will influence cellular growth, tissue regeneration, 
drug delivery and a good patient compliance (Zilberman & Elsner, 2008). Among the 
biopolymers, collagen is one of the most used, being a suitable biodegradable polymeric 
support for drug delivery systems, offering the advantage of a natural biomaterial with 
haemostatic and wound healing properties (Lee et al., 2001). 
Studies with collagen as support showed that in vivo absorption and degradability on the 
one hand and drug delivery on the other hand are controlled by the collagen chemical or 
physical cross-linking performed in order to control the delivery effect (Albu, 2011). 
Among the incorporated drugs in the collagen biomaterials various structures are 
mentioned: antibiotics and antiseptic (tetracycline, doxycicline, rolitetracycline, minocycline, 
metronidazole, ceftazidine, cefotaxime, gentamicin, amikacin, tobramycin, vancomycin, 
clorhexidine), statines (rosuvastatin), vitamines (riboflavine), parasympathomimetic 
alkaloid (pilocarpine) etc. (Zilberman & Elsner, 2008; Goissis & De Sousa, 2009; Yarboro et 
al., 2007).  
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The most known collagen-based drug delivery systems are the hydrogels and matrices. 
The literature in the field reveals the importance of modeling the drug release kinetics from 
systems with topical application. The topical preparations with antibiotics, anti-inflammtories, 
antihistaminics, antiseptics, antimicotics, local anaesthetics must have a rapid realease of the 
drug. The release kinetics has to balance the advantage of reaching a therapeutical 
concentration with the disadvantage of toxic concentrations accumulation (Ghica, 2010). 
As far as the drug delivery kinetics from semisolid/solid systems generally is concerned, it 
has been widely studied only in the case of the hydrogels having quasi-solid structure (Lin 
& Metters, 2006; Albu et al., 2009b). 
In the case of the matrices, there is scarce literature on the delivery and the delivery 
mechanism of the drug from such systems. In Fig. 4 the drug delivery from a spongious 
collagen support is schematically presented. 
The delivery of the drug from polymeric formulations is controlled by one or more physical 
processes including: polymer hydration through fluid, swelling to form a gel, drug diffusion 
through the gel formed and eventual erosion of the polymeric gel. It is possible that, for the 
sponges, the swelling, erosion and the subsequent diffusion kinetics play an important role 
in the release of the drug from these systems upon contact with biological fluids (cutaneous 
wound exsudate/gingival crevicular fluid). Upon contact of a dry sponge with the wet 
surface at the application site, biological fluid from that region penetrates the polymer 
matrix. Thus, the solvent molecules’ internal flux causes the subsequent sponge hydration 
and swelling and the formation of a gel at the application site surface. The swelling noticed 
is due to the polymeric chains solvation that leads to an increase of the distance between the 
individual molecules of the polymer (Peppas et al., 2000; Boateng et al., 2008). 
For some of the spongious forms the drug release mechanism has been explained through 
the hydrolytic activity of the enzymes existing in biological fluids, different mathematical 
models of the collagen sponges’ enzymatic degradation being suggested (Metzmacher et al., 
2007; Radu et al., 2009). 
It was shown that in an aqueous medium the polymer suffers a relaxation process having as 
result the direct, slow erodation of the hydrated polymer. It is possible that its swelling and 
dissolution happen at the same time as in the sponges’ situation, each of these processes 
contributing to the global release mechanism. However, the quantity of the drug released is 
generally determined by the diffusion rate of the medium represented by biological fluid in 
the polymeric sponge. Factors such as polymeric sponge erosion after water diffusion and 
the swelling in other dosage forms are the main reason of kinetics deviation square root of 
time (Higuchi type, generally specific to the hydrogels as such) (Boateng et al., 2008). 
Different methods have been suggested for the investigation of the drug controlled release 
mechanisms that combine the diffusion, the swelling and the erosion. It is assumed that the 
collagen sponge is made of a homogeneous polymeric support where the drug (dissolved or 
suspended) is present in two forms: free or linked to the polymeric chains. The drug as free 
form is available for diffusion, through the desorption phenomenon, for immediate release 
in a first stage, this being favored by the sponge properties behaving as partially open 
porosity systems. The drug amount partially imobilized in collagen fibrillar structure will be 
gradually released after the diffusion of the biologic fluid inside the sponge, followed by its 
swelling and erosion on the basis of polymers reaction in solution theory. This sustained 
release is favored by the matrix properties to act as partially closed porosity systems, as well 
as by the collagen sponge tridimensional structure, which is a barrier between the drug in 
the sponge and the release medium (Singh et al., 1995; Friess, 1998; Wallace & Rosenblatt, 
2003; Ruszczak & Friess; 2003). 
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Fig. 4. Drug release from collagen matrix 
In addition, the drug release kinetics can be influenced by the different chemical treatments 
that affect the degradation rate or by modifications of sponge properties (porosity, density) 
(M. Grassi & G. Grassi, 2005). 
Among the chemical methods we can mention the cross-linking techniques. Thus, the 
different in vivo and in vitro behaviour, including the drug delivery profiles, can be 
obtained if the product based on collagen suffer in addition cross-linking with different 
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cross-linking agents. Among these agents, the most known and used is the glutaraldehyde 
that forms a link between the ε-amino groups of two lateral lysin chains. It was 
demonstrated that the treatment with glutaraldehyde reduces the collagen material 
immunogenicity, leading at the same time to the increase of resistance to enzymatic 
degradation (Figueiro et al., 2006). 
Concerning the preparation of sponges with different porosities, those can be obtained by 
modifying the temperature during the collagen sponges lyophilization process (Albu et al., 
2010a). 
To understand the release process, both from hydrogels and from collagen sponges, and to 
establish the drug release mechanism implicitly, a range of kinetic models is used (Peppas, 
Higuchi, zero order). The general form of the kinetic equation through which the 
experimental kinetic data are fitted is the following: (eq. 1) 
 nt
m
k t
m∞
= ⋅  (1) 
where mt is the amount of drug released at time t, m∞ is the total drug contents in the 
designed collagen hydrogels, mt/m∞  is the fractional release of the drug at the time t, k is 
the kinetic constant, reflecting the structural and geometrical properties of the polymeric 
system and the drug, and n is the release exponent, indicating the mechanism of drug 
release.  
If n=0.5 the release is governed by Fickian diffusion (the drug diffusion rate is much lower 
than the polymer relaxation rate, the amount of drug released being proportional to the 
release time square root, corresponding to Higuchi model). If n=1 the release is controlled 
by surface erosion (the drug diffusion rate is much higher than the polymer relaxation rate, 
the amount of drug released being proportional with the release time, corresponding to zero 
order model). If 0.5<n<1, the drug release mechanism is of non-Fickian type diffusion, the 
drug diffusion rate and the polymer relaxation rate being roughly equal. In this case the 
release is not based only on diffusion, being also associated with other release mechanisms 
due to the complex processes previousely described (Teles et al., 2010; Higuchi, 1962; 
Peppas et al., 2000; Singh et al., 1995; Ho et al., 2001). 
The studied literature shows that Peppas, Higuchi and zero order models do not explain the 
mechanisms involved in the kinetic processes in the case of sponge forms, because the value 
of the apparent release order value (n) does not fit between the limits imposed by these 
aforesaid models, having values much lower than 0.5. This is why an extension of Peppas 
model to the Power law model (0<n<1) is generally applied in order to elucidate the 
complex kinetic mechanisms involved in the drug release from such natural supports. 
Practically, n value includes characteristics of each particular model previously described 
(Ghica et al., 2009; Albu et al., 2009a; Albu et al., 2010b; Phaechamud & Charoenteeraboon, 
2008; Natu et al., 2007). 
Our studies showed values of n equal to 0.5 for different collagen-based hydrogels with 
doxyciclyne, uncross-linked or cross-linked with glutaraldehyde, which confirms the respect 
of Higuchi model concerning the drug release from semisolid supports (Albu et al., 2009b). 
On the contrary, n values for doxycycline release from spongious supports were inferior to 
0.5 (Ghica et al., 2009; Albu et al., 2010a; Albu et al., 2010b). 
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4. Collagen-based scaffolds for tissue engineering 
It is known that collagen is the major component of the extracellular matrix of most tissues. 
As a natural molecule, collagen possesses a major advantage in being biodegradable, 
biocompatible presented low antigenicity, easily available and highly versatile. Collagen 
provides structural and mechanical support to tissues and organs (Gelse et al., 2003) and 
fulfils biomechanical functions in bone, cartilage, skin, tendon, and ligament. For this 
reason, allogenic and xenogenic collagens have been long recognized as one of the most 
useful biomaterials. Collagen can be prepared in a number of different forms with different 
application: shields used in ophthalmology (Rubinstein, 2003; Yoel &  Guy, 2008) matrices 
for burns/wounds (Keck et al., 2009; Wollina et al., 2011), gel formulation in combination 
with liposomes for sustained drug delivery (Wallace & Rosenblatt, 2003; Weiner et al., 1985; 
Rao, 1996), as controlling material for transdermal delivery (Rao,  1996; Thacharodi & Rao,  
1996), nanoparticles for gene delivery (Minakuchi et al., 2004) and basic matrices for cell 
culture systems. Therefore thin sheets and gels are substrates for smooth muscle (Dennis et 
al., 2007; Engler et al., 2004), hepatic (Hansen & Albrecht, 1999;  Ranucci et al., 2000), 
endothelial (Albu et al., 2011; Deroanne et al., 2001; Titorencu et al., 2010), and epithelial 
cells (Haga et al., 2005), while matrices are often used to engineer skeletal tissues such as 
cartilage (Stark et al., 2006; Schulz et al., 2008), tendon (Gonçalves-Neto et al., 2002; Kjaer, 
2004) and bone (Guille et al., 2005). 
It is known that the goal of tissue engineering (TE) is to repair and restore damaged tissue 
function. The three fundamental “tools” for both morphogenesis and tissue engineering are 
responding cells, scaffolds and growth factors (GFs - regulatory biomolecules, morphogens), 
which, however, are not always simultaneously used (Badylak & Nerem, 2010; Berthiaume 
et al., 2011) (Fig. 5). 
In tissue engineering, matrices are developed to support cells, promoting their 
differentiation and proliferation in order to form a new tissue. Another important aspect for 
the generation of 3D cell matrix constructs suitable for tissue regeneration is represented by 
cell seeding. Besides the seeding technique, the cellular density is a crucial factor to achieve 
a uniform distribution of a number of cells which is optimal for new tissue formation (Lode 
et al., 2008). Such strategies allow producing of biohybrid constructs that can be implanted 
in patients to induce the regeneration of tissues or replace failing or malfunctioning organs. 
The advantage of tissue engineering is that small biopsy specimens can be obtained from the 
patient and cells can be isolated, cultured into a structure similar to tissue or organs in the 
living body, expanded into large numbers (Bruder & Fox, 1999; Levenberg & Langer, 2004; 
Mooney & Mikos, 1999; Service, 2005) and then transplanted into the patients. 
The recent advances in collagen scaffold biomaterials are presented as follows: 
Wound dressing and delivery systems 
In the treatment of wounds the collagen-based dressings are intensely used. There are many 
studies which attest the benefits of topical collagen matrices on the wound healing (Inger & 
Richard, 1999; Ruszczak, 2003; Shih-Chi et al., 2008). 
It is known that collagen matrices absorb excess wound exudate or sterile saline, forming 
a biodegradable gel or sheet over the wound bed that keeps the balance of wound 
moisture environment, thus promoting healing (Hess, 2005). Also, collagen breakdown 
products are chemotactic for a variety of cell types required for the formation of 
granulation tissue. Nowadays, many types of skin substitutes using living cells have been 
used clinically (Table 2). 
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Fig. 5. Strategies for tissue engineering 
 
Classification Tissue replaced Layers 
TranCyte® Epidermal Silicone 
Nylon mesh 
Collagen seeded with neonatal fibroblasts 
PermaDermTM  
 
Dermal 
 
Autologous fibroblasts in bovine collagen matrix 
with autologous keratinocytes  
Apligraft® Epidermal and dermal Neonatal keratinocytes  
Collagen seeded with neonatal fibroblasts  
OrCellTM Epidermal and dermal Collagen (bovine type I) seeded with allogenic 
fibroblasts and keratinocytes 
Table 2. Classification of collagen substitutes with living cells 
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These biomaterials can be divided into three groups depending on the type of layer cells 
which are substituted. The first type consists of grafts of cultured epidermal cells with no 
dermal components. The second type has only dermal components. The third type is a 
bilayer containing both dermal and epidermal elements. 
Bone defects 
Bone development and regeneration occurs as a result of coordinated cell proliferation, 
differentiation, migration, and remodeling of the extracellular matrix. In bone tissue 
engineering collagen scaffolds play an essential role in supporting bone regeneration. The 
implantation of these 3D biomaterials is necessary when osteochondral defects reach an 
important volume or when autografts have to be avoided for practical or pathological 
reasons. In order to promote bone healing scaffolds must have some properties: to promote 
the differentiation of immature progenitor cells into osteoblasts (osteoinduction), to induce 
the ingrowth of surrounding bone (osteoconduction) and to be integrated into the 
surrounding tissue (osseointegration) (Dickson et al., 2007). However there is still some 
ambiguity regarding the optimal porosity and pore size for a 3D bone scaffold. A literature 
review indicates that a pore size in the range of 10–400 µm may provide enough nutrient 
and osteoblast cellular infusion, while maintaining structural integrity (Bignon et al., 2003; 
Holmbom et al., 2005; Woodard et al., 2007).  
Collagen scaffolds have the advantage of facilitating cell attachment and maintaining 
differentiation of cells (Fig. 6). Resorbable collagen sponges have been successfully used as 
carriers of BMP-2, BMP-4 and BMP-7 but they have the disadvantages of a fast degradation 
rate and low mechanical strength (Bessa et al., 2008; Higuchi et al., 1999; Huang et al., 2005;   
Huang et al., 2005; Kinoshita et al., 1997;).  
 
 
 
Fig. 6. Human osteoblasts precursor cells (hFOB1.19) grown seven days on collagen 
scaffolds 
In order to increase mechanical strength and to improve the release of growth factors a 
combination between collagen and other natural polymer has been used such as chitosan 
(Arpornmaeklong et al., 2007), dextran (Fig. 7) or glycosaminoglycans (Harley & Gibson, 
2008; Wang et al., 2010). 
Another combination of collagen scaffolds is represented by mineralization with calcium 
phosphate (Du et al., 2000; Harley et al., 2010) and/or on cross-linking with other substances 
like hydroxyapatite (Dubey & Tomar, 2009; Liao et al., 2009.) or bushite (Tebb et al., 2006). 
www.intechopen.com
 
Biomaterials Applications for Nanomedicine 
 
346 
 
Fig. 7. Osteosarcoma cells (MG 63) grown on collagen-dextran scaffold: a – phase contrast,  b 
– Hoechst nuclear staining 
Urogenital system 
Injuries of the genitourinary system can lead to bladder damage.  Treatment in most of these 
situations requires eventual reconstructive procedures that can be performed with native 
non-urologic tissues (skin, gastrointestinal segments or mucosa), heterologous tissues or 
substances (bovine collagen) or artificial materials (Atala, 2011). Acellular collagen scaffolds 
were used in the treatment of bladder augmentation (Akbal et al., 2006; Liu et al., 2009; 
Parshotamet al., 2010) and urethral stricture (el-Kassaby et al., 2008; Farahat et al., 2009). 
Also collagen-composite scaffolds populated with the patient’s own urothelial and muscle 
cells or self-assembled fibroblast sheets represent a promising strategy for bladder 
augmentation (Bouhout et al., 2010; Magnan et al., 2006). Trials of urethral tissue 
replacement with processed collagen matrices are in progress, and bladder replacement 
using tissue engineering techniques are intensely being studied (Atala et al., 2006). 
Scaffolds for hepatic cells 
Recent new strategies for treating liver diseases, including the extracorporeal bioartificial 
liver device and hepatocyte transplantation represent the future in hepatic diseases 
treatment. Recent advances in the field of tissue engineering have demonstrated that type I 
collagen matrices induced the differentiation of hepatic stem-like cells into liver epithelial 
cells and that biodegradable collagen matrices provide an appropriate microenvironment 
for hepatocytic repopulation (Uneo et al., 2004;Ueno et al., 2005.); also, a combination 
between collagen-chitosan-heparin scaffolds was used in order to obtain bioartificial liver 
(Xing et al., 2005). 
Cornea and neural cells 
Bioengineered corneas are substitutes for human donor tissue that are designed to replace 
part or the full thickness of damaged or diseased corneas. Collagen has been used 
successfully in reconstruction of artificial cornea alone by delivery of limbal epithelial stem 
cells to damaged cornea (Builles et al., 2010; De Miguel et al., 2010) or in combination with 
glycosaminoglycan (GAG) molecules (Auxenfans et al., 2009). The combination of collagen 
biomaterials and stem cells could be a valuable strategy to treat corneal defects also. Other 
strategies in collagen-based corneal scaffolds include the utilization of recombinant human 
collagen (Dravida et al., 2008; Griffith et al., 2009), the secretion of collagen by the fibroblasts 
themselves (Carrier et al., 2008) and surface modification to reduce extensive 
endothelialization (Rafat et al., 2009). 
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Nerve repairing 
One of the major challenges in neurology is to be able to repair severe nerve trauma. It was 
observed that collagen scaffolds is a suitable nerve guidance material (Han et al., 2010) Most 
collagen nerve guides are engineered from crosslinked collagen with tubular shape such as 
commercially available NeuraGen® from Integra™. Recent tissue engineering strategies 
involve addition of neurotrophic factors into collagen scaffolds (Sun et al., 2007; Sun et al., 
2009) and cell delivery (Bozkurt et al., 2009; Kemp et al., 2009) in order to attempt to enhance 
nerve guides. 
5. Conclusion  
Collagen biomaterials as matrices, hydrogels, composites have already been proved to be 
effective in tissue repairing, in guiding functional angiogenesis and in controlling stem cell 
differentiation. Also, collagen-based drug delivery systems were studied and their 
mechanisms of release were determined. Based on such good results, the promising next 
generation of engineered tissues is relying on producing scaffolds which can prolong the 
release rate of growth factors or cells in order to increase their therapeutic effect. This 
justifies the importance of drug delivery in tissue engineering applications.  
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